These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8615005)

  • 1. Epithelial cells display separate receptors for papillomavirus VLPs and for soluble L1 capsid protein.
    Qi YM; Peng SW; Hengst K; Evander M; Park DS; Zhou J; Frazer IH
    Virology; 1996 Feb; 216(1):35-45. PubMed ID: 8615005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses.
    Evander M; Frazer IH; Payne E; Qi YM; Hengst K; McMillan NA
    J Virol; 1997 Mar; 71(3):2449-56. PubMed ID: 9032382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes.
    Joyce JG; Tung JS; Przysiecki CT; Cook JC; Lehman ED; Sands JA; Jansen KU; Keller PM
    J Biol Chem; 1999 Feb; 274(9):5810-22. PubMed ID: 10026203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface-binding motifs of L2 that facilitate papillomavirus infection.
    Yang R; Day PM; Yutzy WH; Lin KY; Hung CF; Roden RB
    J Virol; 2003 Mar; 77(6):3531-41. PubMed ID: 12610128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus type 6b virus-like particles are able to activate the Ras-MAP kinase pathway and induce cell proliferation.
    Payne E; Bowles MR; Don A; Hancock JF; McMillan NA
    J Virol; 2001 May; 75(9):4150-7. PubMed ID: 11287564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer using recombinant rabbit hemorrhagic disease virus capsids with genetically modified DNA encapsidation capacity by addition of packaging sequences from the L1 or L2 protein of human papillomavirus type 16.
    El Mehdaoui S; Touzé A; Laurent S; Sizaret PY; Rasschaert D; Coursaget P
    J Virol; 2000 Nov; 74(22):10332-40. PubMed ID: 11044077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer.
    Baek JO; Seo JW; Kwon O; Park SM; Kim CH; Kim IH
    Enzyme Microb Technol; 2012 Mar; 50(3):173-80. PubMed ID: 22305172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear localization but not PML protein is required for incorporation of the papillomavirus minor capsid protein L2 into virus-like particles.
    Becker KA; Florin L; Sapp C; Maul GG; Sapp M
    J Virol; 2004 Feb; 78(3):1121-8. PubMed ID: 14722267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation of human papillomavirus type 16 L1 protein.
    Zhou J; Sun XY; Frazer IH
    Virology; 1993 May; 194(1):210-8. PubMed ID: 8386874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells.
    Volpers C; Unckell F; Schirmacher P; Streeck RE; Sapp M
    J Virol; 1995 Jun; 69(6):3258-64. PubMed ID: 7745672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human papillomavirus type 6 L1 and L2 isolated in China and self assembly of virus-like particles by the products.
    Wang M; Wang LL; Chen LF; Han YH; Zou YH; Si JY; Song GX
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Jan; 35(1):27-34. PubMed ID: 12518224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly.
    Li M; Cripe TP; Estes PA; Lyon MK; Rose RC; Garcea RL
    J Virol; 1997 Apr; 71(4):2988-95. PubMed ID: 9060658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Papillomavirus capsid binding and uptake by cells from different tissues and species.
    Müller M; Gissmann L; Cristiano RJ; Sun XY; Frazer IH; Jenson AB; Alonso A; Zentgraf H; Zhou J
    J Virol; 1995 Feb; 69(2):948-54. PubMed ID: 7815562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies: basis for a virus-like particle ELISA.
    Rommel O; Dillner J; Fligge C; Bergsdorf C; Wang X; Selinka HC; Sapp M
    J Med Virol; 2005 Jan; 75(1):114-21. PubMed ID: 15543569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine pneumotropic virus VP1 virus-like particles (VLPs) bind to several cell types independent of sialic acid residues and do not serologically cross react with murine polyomavirus VP1 VLPs.
    Tegerstedt K; Andreasson K; Vlastos A; Hedlund KO; Dalianis T; Ramqvist T
    J Gen Virol; 2003 Dec; 84(Pt 12):3443-3452. PubMed ID: 14645925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.
    Christensen ND; Cladel NM; Reed CA; Budgeon LR; Embers ME; Skulsky DM; McClements WL; Ludmerer SW; Jansen KU
    Virology; 2001 Dec; 291(2):324-34. PubMed ID: 11878901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
    Kawana Y; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
    J Virol; 2001 Mar; 75(5):2331-6. PubMed ID: 11160736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation, renaturation, and self-assembly of virus-like particles in vitro.
    Zhang W; Carmichael J; Ferguson J; Inglis S; Ashrafian H; Stanley M
    Virology; 1998 Apr; 243(2):423-31. PubMed ID: 9568041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced papillomavirus-like particle production in insect cells.
    Senger T; Schädlich L; Gissmann L; Müller M
    Virology; 2009 Jun; 388(2):344-53. PubMed ID: 19409593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.